MARKET REVIEW 4 Saham Ini Bikin IHSG Terkoreksi - Media Asuransi
| KLBF Stock | IDR 1,490 10.00 0.67% |
About 61% of Kalbe Farma's investor base is looking to short. The analysis of current outlook of investing in Kalbe Farma Tbk suggests that many traders are alarmed regarding Kalbe Farma's prospects. Kalbe Farma's investing sentiment shows overall attitude of investors towards Kalbe Farma Tbk.
Kalbe |
MARKET REVIEW 4 Saham Ini Bikin IHSG Terkoreksi Media Asuransi
Read at news.google.com
 |
Kalbe Farma Fundamental Analysis
We analyze Kalbe Farma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kalbe Farma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kalbe Farma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Kalbe Farma is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Kalbe Farma Tbk Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kalbe Farma stock to make a market-neutral strategy. Peer analysis of Kalbe Farma could also be used in its relative valuation, which is a method of valuing Kalbe Farma by comparing valuation metrics with similar companies.
Peers
Kalbe Farma Related Equities
| CMNP | Citra Marga | 1.06 | ||||
| LTLS | Lautan Luas | 0.50 | ||||
| HEXA | Hexindo Adiperkasa | 1.03 | ||||
| ASGR | Astra Graphia | 1.16 |
Other Information on Investing in Kalbe Stock
Kalbe Farma financial ratios help investors to determine whether Kalbe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kalbe with respect to the benefits of owning Kalbe Farma security.